Menu

Events and conference calls

You are here

  1. Home
  2. Media and investors
  3. MorphoSys events

Company calendar 2020

One of the main goals of the corporate communications function at MorphoSys is to inform stakeholders about the achievements and the developments within the company in an open and timely manner. Please see our full program listings for further details.

Date
Title
Add to Calendar
  1. 03/18/2020

    Year-End Results 2019

  2. 05/06/2020

    First Quarter Interim Statement 2020

  3. 05/27/2020

    Annual General Meeting 2020

  4. 08/05/2020

    Half-Year Report 2020

  5. 11/11/2020

    Third Quarter Interim Statement 2020

Upcoming
conferences

Wed
05
'20
Aug

Half-Year Report 2020

add date
Wed
11
'20
Nov

Third Quarter Interim Statement 2020

add date
Sat-Tue
05-08
'20
Dec
Dec

62nd ASH Annual Meeting & Exposition

San Diego, California, USA
add date

Conference Archive

Date
Title
MP3

2020

  1. 06/18/2020

    Webcast: JMP Securities Hematology and Oncology Forum

  2. 06/10/2020

    Webcast: Goldman Sachs 41st Annual Global Healthcare Conference

  3. 06/03/2020

    Webcast: Jefferies 2020 Healthcare Conference

  4. 05/07/2020

    Conference Call and Webcast: Q1 2020 Financial Results

  5. 03/19/2020

    Conference Call and Webcast: Year End 2019

  6. 02/26/2020

    Webcast: 9th Annual SVB Leerink Global Healthcare Conference

  7. 01/15/2020

    Webcast: 38th Annual J.P. Morgan Healthcare Conference

  8. 01/13/2020

    Joint Conference Call MorphoSys and Incyte on the Global Collaboration and License Agreement for Tafasitamab

2019

  1. 12/03/2019

    31st Annual Piper Jaffray Healthcare Conference

  2. 11/25/2019

    Presentation: German Eigenkapitalforum

  3. 10/30/2019

    Conference Call and Webcast: Q3 2019 Financial Results

  4. 09/25/2019

    Presentation: 8th Annual Goldman Sachs and Berenberg German Corporate Conference

  5. 08/27/2019

    Presentation: Commerzbank Sector Conference 2019

  6. 08/07/2019

    Conference Call and Webcast: Q2 2019 Financial Results